102
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Postoperative Intestinal Fistula in Primary Advanced Ovarian Cancer Surgery

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & show all
Pages 13-23 | Published online: 06 Jan 2021

References

  • Sociedad Española de Oncología Médica (SEOM). Full-Text. Las cifras del cáncer en España 2018 [Internet]; 2018 24 Available from: https://seom.org/seomcms/images/stories/recursos/Las_Cifras_del_cancer_en_Espana2018.pdf. Accessed 1217, 2020.
  • Du Bois A, Reuss A, Pujade-Lauraine E. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized Phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO). Cancer. 2009;115(6):1234. doi:10.1002/cncr.2414919189349
  • Bartels HC, Rogers AC, Postle J, et al. Morbidity and mortality in women with advanced ovarian cancer who underwent primary cytoreductive surgery compared to cytoreductive surgery for recurrent disease: a meta-analysis. Pleura Peritoneum. 2019;4(2):20190014. doi:10.1515/pp-2019-001431417960
  • Llueca A, Herraiz JL, Catala C. Effectiveness and safety of cytoreduction surgery in advanced ovarian cancer: initial experience at a University General Hospital. J Clin Gynecol Obstetrics. 2015;4(3):251–257. doi:10.14740/jcgo345w
  • Llueca A, Serra A, Maiocchi K, et al. Predictive model for major complications after extensive abdominal surgery in primary advanced ovarian cancer. Int J Women’s Health. 2019;11:161–167. doi:10.2147/IJWH.S19049330881145
  • Hoffman MS, Zervose E. Colon resection for ovarian cancer: intraoperative decisions. Gynecol Oncol. 2008;111(2):S 56–65. doi:10.1016/j.ygyno.2008.07.055
  • Tebes SJ, Cardosi R, Hoffman MS. Colorectal resection in patients with ovarian and primary peritoneal carcinoma. Am J Obstet Gynecol. 2006;195(2):585–589. doi:10.1016/j.ajog.2006.03.07916730631
  • Bristow RE, Peiretti M, Gerardi M, et al. Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome. Gynecol Oncol. 2009;114(2):173–177. doi:10.1016/j.ygyno.2009.05.00419482344
  • Kato K, Nomura H, Nagashima M, Takeshima N. Secondary debulking surgery for isolated pelvic nodal recurrence requiring external iliac vein excision and reconstruction in a patient with ovarian cancer. Gynecol Oncol. 2016;143(3):684–685. doi:10.1016/j.ygyno.2016.09.00827629915
  • Llueca A, Serra-Rubert A, Escrig J. MUAPOS working group (Multidisciplinary Unit of Abdominal Pelvic Oncology Surgery). Prognostic value of peritoneal cancer index in primary advanced ovarian cancer. Eur J Surg Oncol. 2018;44:163–169. doi:10.1016/j.ejso.2017.11.00329198495
  • Clavien PA, Sanabria JR, Strasberg SM. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery. 1992;111:518–526.1598671
  • Goenka MK, Goenka U. Endotherapy of leaks and fistula. World J Gastrointest Endosc. 2015;7(7):702–713. doi:10.4253/wjge.v7.i7.70226140097
  • Prat J. FIGO Committee on Gynecologic Oncology. Staging Classification for cancer of the Ovary, Fallopian tube, and peritoneum. Int J Gynecol Obstet. 2014;124:1–5. doi:10.1016/j.ijgo.2013.10.001
  • Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg. 1995;221(2):124–132. doi:10.1097/00000658-199502000-000027857141
  • Koscielny A, Ko A, Egger E, Kuhn W, Kalff JC, Keyver-Paik MD. Prevention of anastomotic leakage in ovarian cancer debulking surgery and Its impact on overall survival. Anticancer Res. 2019;39(9):5209–5218.31519635
  • Kalogera E, Dowdy SC, Mariani A, et al. Multiple large bowel resections: potential risk factor for anastomotic leak. Gynecol Oncol. 2013;130(1):213–218. doi:10.1016/j.ygyno.2013.04.00223578541
  • Bartl T, Schwameis R, Stift A, et al. Predictive and prognostic implication of bowel resections during primary cytoreductive surgery in advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2018;28(9):1664–1671. doi:10.1097/IGC.000000000000136930371563
  • Llueca A, Serra A, Rivadulla I, Gomez L, Escrig J. MUAPOS working group (multidisciplinary unit of abdominal pelvic oncology surgery). Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index. World J Surg Oncol. 2018;16:37. doi:10.1186/s12957-018-1339-029471831
  • Glasgow MA, Shields K, Vogel RI, Teoh D, Argenta PA. Postoperative readmissions following ileostomy formation among patients with a gynecologic malignancy. Gynecol Oncol. 2014;134(3):561–565. doi:10.1016/j.ygyno.2014.06.00524933101
  • Richardson DL, Mariani A, Cliby WA. Risk factors for anastomotic leak after recto-sigmoid resection for ovarian cancer. Gynecol Oncol. 2006;103(2):667–672. doi:10.1016/j.ygyno.2006.05.00316797684
  • Garcia Martínez T, Montanes Pauls B, Vicedo Cabrera A, et al. Evaluacion y soporte nutricional en pacientes con carcinomatosis peritoneal por cáncer de ovario con citorreducción quiruúrgica. Nutr Cli´n Diet Hosp. 2016;36(1):31–40.
  • Oldham MC, Langfelder P, Horvath S. Network methods for describing sample relationships in genomic datasets: application to Huntington’s disease. BMC Syst Biol. 2012;6(63). doi:10.1186/1752-0509-6-63.
  • Grimm C, Harter P, Alesina PF, et al. The impact of type and number of bowel resections on anastomotic leakage risk in advanced ovarian cancer surgery. Gynecol Oncol. 2017;146(3):498–503. doi:10.1016/j.ygyno.2017.06.00728610745
  • Gallotta V, Fanfani F, Vizzielli G. Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: analysis of morbidity and oncological outcome. Eur J Surg Oncol. 2011;37(12):1085–1092. doi:10.1016/j.ejso.2011.09.00321945640
  • Gallotta V, Fanfani F, Fagotti A. Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: prognostic role and clinical considerations. Ann Surg Oncol. 2014;21(7):2369–2375. doi:10.1245/s10434-014-3558-024558070